Evidence map›Paper›PMID 36174483›Full record

ArticleEnvironment international2022

Systematic evidence map (SEM) template: Report format and methods used for the US EPA Integrated Risk Information System (IRIS) program, Provisional Peer Reviewed Toxicity Value (PPRTV) program, and other "fit for purpose" literature-based human health analyses.

Kristina A Thayer, Michelle Angrish, Xabier Arzuaga, Laura M Carlson, Allen Davis, Laura Dishaw, Ingrid Druwe, Catherine Gibbons, Barbara Glenn, Ryan Jones and 29 more

Erratum issuedAbstract read
In one paragraph

Article in Environment international, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

39 authors.

Kristina A ThayerCenter for Public Health and Environmental Assessment, Chemical & Pollutant Assessment Division, US EPA, DC, USA. Electronic address: thayer.kris@epa.gov.
Michelle AngrishCenter for Public Health and Environmental Assessment, Chemical & Pollutant Assessment Division, US EPA, DC, USA. Electronic address: angrish.michelle@epa.gov.
Xabier ArzuagaCenter for Public Health and Environmental Assessment, Chemical & Pollutant Assessment Division, US EPA, DC, USA. Electronic address: Arzuaga.Xabier@epa.gov.
Laura M CarlsonCenter for Public Health and Environmental Assessment, Health & Environmental Effects Assessment Division, US EPA, NC, USA. Electronic address: Carlson.Laura@epa.gov.
Allen DavisCenter for Public Health and Environmental Assessment, Chemical & Pollutant Assessment Division, US EPA, DC, USA. Electronic address: Davis.Allen@epa.gov.
Laura DishawCenter for Public Health and Environmental Assessment, Chemical & Pollutant Assessment Division, US EPA, DC, USA. Electronic address: Dishaw.Laura@epa.gov.
Ingrid DruweCenter for Public Health and Environmental Assessment, Chemical & Pollutant Assessment Division, US EPA, DC, USA. Electronic address: Druwe.Ingrid@epa.gov.
Catherine GibbonsCenter for Public Health and Environmental Assessment, Chemical & Pollutant Assessment Division, US EPA, DC, USA. Electronic address: Gibbons.Catherine@epa.gov.
Barbara GlennCenter for Public Health and Environmental Assessment, Chemical & Pollutant Assessment Division, US EPA, DC, USA. Electronic address: Glenn.Barbara@epa.gov.
Ryan JonesCenter for Public Health and Environmental Assessment, Health & Environmental Effects Assessment Division, US EPA, NC, USA. Electronic address: Jones.Ryan@epa.gov.
J Phillip KaiserCenter for Public Health and Environmental Assessment, Chemical & Pollutant Assessment Division, US EPA, DC, USA. Electronic address: Kaiser.Jonathan-Phillip@epa.gov.
Channa KeshavaCenter for Public Health and Environmental Assessment, Chemical & Pollutant Assessment Division, US EPA, DC, USA. Electronic address: Keshava.Channa@epa.gov.
Nagalakshmi KeshavaCenter for Public Health and Environmental Assessment, Chemical & Pollutant Assessment Division, US EPA, DC, USA. Electronic address: keshava.nagu@epa.gov.
Andrew KraftCenter for Public Health and Environmental Assessment, Chemical & Pollutant Assessment Division, US EPA, DC, USA. Electronic address: kraft.andrew@epa.gov.
Lucina LizarragaCenter for Public Health and Environmental Assessment, Chemical & Pollutant Assessment Division, US EPA, DC, USA. Electronic address: lizarraga.lucina@epa.gov.
Amanda PersadCenter for Public Health and Environmental Assessment, Chemical & Pollutant Assessment Division, US EPA, DC, USA. Electronic address: persad.Amanda@epa.gov.
Elizabeth G RadkeCenter for Public Health and Environmental Assessment, Chemical & Pollutant Assessment Division, US EPA, DC, USA. Electronic address: radke-farabaugh.elizabeth@epa.gov.
Glenn RiceCenter for Public Health and Environmental Assessment, Chemical & Pollutant Assessment Division, US EPA, DC, USA. Electronic address: rice.glenn@epa.gov.
Brittany SchulzOak Ridge Associated Universities, TN, USA. Electronic address: schulz.brittany@epa.gov.
Rachel M ShafferCenter for Public Health and Environmental Assessment, Chemical & Pollutant Assessment Division, US EPA, DC, USA. Electronic address: Shaffer.rachel@epa.gov.
Teresa ShannonCenter for Public Health and Environmental Assessment, Chemical & Pollutant Assessment Division, US EPA, DC, USA. Electronic address: Shannon.Teresa@epa.gov.
Andrew ShapiroCenter for Public Health and Environmental Assessment, Health & Environmental Effects Assessment Division, US EPA, NC, USA. Electronic address: Shapiro.Andy@epa.gov.
Shane ThackerCenter for Public Health and Environmental Assessment, Health & Environmental Effects Assessment Division, US EPA, NC, USA. Electronic address: Thacker.Samuel@epa.gov.
Suryanarayana V VulimiriCenter for Public Health and Environmental Assessment, Chemical & Pollutant Assessment Division, US EPA, DC, USA. Electronic address: Vulimiri.Sury@epa.gov.
Antony J WilliamsCenter for Computational Toxicology and Exposure, US EPA, NC, USA. Electronic address: Williams.Antony@epa.gov.
George WoodallCenter for Public Health and Environmental Assessment, Health & Environmental Effects Assessment Division, US EPA, NC, USA. Electronic address: Woodall.George@epa.gov.
Erin YostCenter for Public Health and Environmental Assessment, Chemical & Pollutant Assessment Division, US EPA, DC, USA. Electronic address: Yost.Erin@epa.gov.
Robyn BlainICF, VA, USA. Electronic address: robyn.blain@icf.com.
Katherine DukeICF, VA, USA. Electronic address: katie.duke@icf.com.
Alexandra E GoldstoneICF, VA, USA. Electronic address: Ali.Goldstone@icf.com.
Pam HartmanICF, VA, USA. Electronic address: pamela.hartman@icf.com.
Kevin HobbieICF, VA, USA. Electronic address: kevin.hobbie@icf.com.
Brandall IngleICF, VA, USA. Electronic address: Ingle.Brandall@epa.gov.
Courtney LemerisICF, VA, USA. Electronic address: courtney.lemeris@icf.com.
Cynthia LinICF, VA, USA. Electronic address: cynthia.lin@icf.com.
Alex LindahlICF, VA, USA. Electronic address: alexander.lindahl@icf.com.
Kristen McKinleyICF, VA, USA. Electronic address: kristen.mckinley@icf.com.
Parnian SoleymaniICF, VA, USA. Electronic address: parnian.soleymani@icf.com.
Nicole VetterICF, VA, USA. Electronic address: nicole.vetter@icf.com.

Funding

EPA 68HERC19D0003Intramural EPA EPA999999
6 · The paper itself

Abstract

backgroundSystematic evidence maps (SEMs) are gaining visibility in environmental health for their utility to serve as problem formulation tools and assist in decision-making, especially for priority setting. SEMs are now routinely prepared as part of the assessment development process for the US Environmental Protection Agency (EPA) Integrated Risk Information System (IRIS) and Provisional Peer Reviewed Toxicity Value (PPRTV) assessments. SEMs can also be prepared to explore the available literature for an individual chemical or groups of chemicals of emerging interest.

objectivesThis document describes the typical methods used to produce SEMs for the IRIS and PPRTV Programs, as well as "fit for purpose" applications using a variety of examples drawn from existing analyses. It is intended to serve as an example base template that can be adapted as needed for the specific SEM. The presented methods include workflows intended to facilitate rapid production. The Populations, Exposures, Comparators and Outcomes (PECO) criteria are typically kept broad to identify mammalian animal bioassay and epidemiological studies that could be informative for human hazard identification. In addition, a variety of supplemental content is tracked, e.g., studies presenting information on in vitro model systems, non-mammalian model systems, exposure-level-only studies in humans, pharmacokinetic models, and absorption, distribution, metabolism, and excretion (ADME). The availability of New Approach Methods (NAMs) evidence is also tracked (e.g., high throughput, transcriptomic, in silico, etc.). Genotoxicity studies may be considered as PECO relevant or supplemental material, depending on the topic and context of the review. Standard systematic review practices (e.g., two independent reviewers per record) and specialized software applications are used to search and screen the literature and may include the use of machine learning software. Mammalian bioassay and epidemiological studies that meet the PECO criteria after full-text review are briefly summarized using structured web-based extraction forms with respect to study design and health system(s) assessed. Extracted data is available in interactive visual formats and can be downloaded in open access formats. Methods for conducting study evaluation are also presented which is conducted on a case-by-case basis, depending on the usage of the SEM.

Indexed as

Environmental HealthResearch DesignAnimalsEpidemiologic StudiesHumansInformation SystemsMammalsUnited StatesUnited States Environmental Protection AgencyHazard characterizationRisk assessmentScoping reviewSystematic evidence mapSystematic reviewToxicity

Identifiers

PMID36174483
PMCPMC12044641

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.